Mark Steven Hamra, MD | |
817 S Elm Pl, Ste 107, Broken Arrow, OK 74012-5369 | |
(918) 259-3141 | |
(918) 258-1266 |
Full Name | Mark Steven Hamra |
---|---|
Gender | Male |
Speciality | Allergy & Immunology |
Location | 817 S Elm Pl, Broken Arrow, Oklahoma |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164428215 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 17578 (Oklahoma) | Primary |
Entity Name | Diversity Health And Wellness |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790418283 PECOS PAC ID: 6709255714 Enrollment ID: O20221214002514 |
News Archive
An international study of dialysis patients shows that although U.S. residents have the highest out-of-pocket drug costs, even those who can afford their prescription drugs are far less likely to take them than patients in other countries.
A new deep learning model could more accurately predict a woman's risk of developing breast cancer than current risk assessment tools.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced enrollment initiation for a 120-patient, international pivotal clinical study to evaluate the safety and efficacy of the DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System designed to resorb in the body within 1 to 2 years after implantation and return the patients' coronary vessel to de novo state.
New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mark Steven Hamra, MD 9913 S 87th East Ave, Tulsa, OK 74133-5593 Ph: (918) 250-0087 | Mark Steven Hamra, MD 817 S Elm Pl, Ste 107, Broken Arrow, OK 74012-5369 Ph: (918) 259-3141 |
News Archive
An international study of dialysis patients shows that although U.S. residents have the highest out-of-pocket drug costs, even those who can afford their prescription drugs are far less likely to take them than patients in other countries.
A new deep learning model could more accurately predict a woman's risk of developing breast cancer than current risk assessment tools.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced enrollment initiation for a 120-patient, international pivotal clinical study to evaluate the safety and efficacy of the DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System designed to resorb in the body within 1 to 2 years after implantation and return the patients' coronary vessel to de novo state.
New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates.
› Verified 8 days ago
Dr. Bret Rice Haymore, MD Allergy & Immunology Medicare: May Accept Medicare Assignments Practice Location: 4716 W Urbana St, Suite 211, Broken Arrow, OK 74012 Phone: 918-994-5200 Fax: 918-994-5222 |